Work

Aberrant tumor metabolism to enable glucocorticoid receptor takeover in enzalutamide-resistant prostate cancer.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.6_suppl.157

Authors: Nima Sharifi, Jianneng Li, Mohammad Alyamani, Ao Zhang, Kai-Hsiung Chang, Mike Berk, Zhenfei Li, Ziqi Zhu, Marianne Petro, Mary-Ellen Taplin, Jorge A. Garcia, Kevin Dale Courtney, Eric A. Klein

Institutions: Cleveland Clinic, Dana-Farber Cancer Institute, The University of Texas Southwestern Medical Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2601872193

Cites:

Cited by:

Related to: 10